Skip to main content
Top
Published in: Diabetologia 2/2014

01-02-2014 | Article

Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet

Authors: Islam N. Mohamed, Sherif S. Hafez, Arwa Fairaq, Adviye Ergul, John D. Imig, Azza B. El-Remessy

Published in: Diabetologia | Issue 2/2014

Login to get access

Abstract

Aims/hypothesis

Obesity and hypertension, known pro-inflammatory states, are identified determinants for increased retinal microvascular abnormalities. However, the molecular link between inflammation and microvascular degeneration remains elusive. Thioredoxin-interacting protein (TXNIP) is recognised as an activator of the NOD-like receptor pyrin domain containing-3 (NLRP3) inflammasome. This study aims to examine TXNIP expression and elucidate its role in endothelial inflammasome activation and retinal lesions.

Methods

Spontaneously hypertensive (SHR) and control Wistar (W) rats were compared with groups fed a high-fat diet (HFD) (W+F and SHR+F) for 8–10 weeks.

Results

Compared with W controls, HFD alone or in combination with hypertension significantly induced formation of acellular capillaries, a hallmark of retinal ischaemic lesions. These effects were accompanied by significant increases in lipid peroxidation, nitrotyrosine and expression of TXNIP, nuclear factor κB, TNF-α and IL-1β. HFD significantly increased interaction of TXNIP–NLRP3 and expression of cleaved caspase-1 and cleaved IL-1β. Immunolocalisation studies identified TXNIP expression within astrocytes and Müller cells surrounding retinal endothelial cells. To model HFD in vitro, human retinal endothelial (HRE) cells were stimulated with 400 μmol/l palmitate coupled to BSA (Pal-BSA). Pal-BSA triggered expression of TXNIP and its interaction with NLRP3, resulting in activation of caspase-1 and IL-1β in HRE cells. Silencing Txnip expression in HRE cells abolished Pal-BSA-mediated cleaved IL-1β release into medium and cell death, evident by decreases in cleaved caspase-3 expression and the proportion of live to dead cells.

Conclusions/interpretation

These findings provide the first evidence for enhanced TXNIP expression in hypertension and HFD-induced retinal oxidative/inflammatory response and suggest that TXNIP is required for HFD-mediated activation of the NLRP3 inflammasome and the release of IL-1β in endothelial cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nguyen TT, Wong TY (2006) Retinal vascular manifestations of metabolic disorders. Trends Endocrinol Metab 17:262–268PubMedCrossRef Nguyen TT, Wong TY (2006) Retinal vascular manifestations of metabolic disorders. Trends Endocrinol Metab 17:262–268PubMedCrossRef
2.
go back to reference Liew G, Wang JJ (2007) Retinal vascular signs in diabetes and hypertension—review. Arq Bras Endocrinol Metabol 51:352–362PubMedCrossRef Liew G, Wang JJ (2007) Retinal vascular signs in diabetes and hypertension—review. Arq Bras Endocrinol Metabol 51:352–362PubMedCrossRef
3.
go back to reference Klein R, Myers CE, Lee KE, Klein BE (2010) 15-Year cumulative incidence and associated risk factors for retinopathy in nondiabetic persons. Arch Ophthalmol 128:1568–1575PubMedCentralPubMedCrossRef Klein R, Myers CE, Lee KE, Klein BE (2010) 15-Year cumulative incidence and associated risk factors for retinopathy in nondiabetic persons. Arch Ophthalmol 128:1568–1575PubMedCentralPubMedCrossRef
4.
go back to reference van Leiden HA, Dekker JM, Moll AC et al (2003) Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 121:245–251PubMedCrossRef van Leiden HA, Dekker JM, Moll AC et al (2003) Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 121:245–251PubMedCrossRef
5.
go back to reference Kratz M, Baars T, Guyenet S (2013) The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur J Nutr 52:1–24PubMedCrossRef Kratz M, Baars T, Guyenet S (2013) The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur J Nutr 52:1–24PubMedCrossRef
6.
go back to reference Wen H, Gris D, Lei Y et al (2011) Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12:408–415PubMedCrossRef Wen H, Gris D, Lei Y et al (2011) Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12:408–415PubMedCrossRef
7.
go back to reference Staiger H, Staiger K, Stefan N et al (2004) Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. Diabetes 53:3209–3216PubMedCrossRef Staiger H, Staiger K, Stefan N et al (2004) Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. Diabetes 53:3209–3216PubMedCrossRef
9.
go back to reference Karpe F, Dickmann JR, Frayn KN (2011) Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60:2441–2449PubMedCrossRef Karpe F, Dickmann JR, Frayn KN (2011) Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60:2441–2449PubMedCrossRef
10.
go back to reference Pejnovic NN, Pantic JM, Jovanovic IP et al (2013) Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets. Diabetes 62:1932–1944PubMedCrossRef Pejnovic NN, Pantic JM, Jovanovic IP et al (2013) Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets. Diabetes 62:1932–1944PubMedCrossRef
11.
go back to reference Matsuzaka T, Atsumi A, Matsumori R et al (2012) Elovl6 promotes nonalcoholic steatohepatitis. Hepatology 56:2199–2208PubMedCrossRef Matsuzaka T, Atsumi A, Matsumori R et al (2012) Elovl6 promotes nonalcoholic steatohepatitis. Hepatology 56:2199–2208PubMedCrossRef
12.
go back to reference Stienstra R, van Diepen JA, Tack CJ et al (2011) Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A 108:15324–15329PubMedCentralPubMedCrossRef Stienstra R, van Diepen JA, Tack CJ et al (2011) Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A 108:15324–15329PubMedCentralPubMedCrossRef
13.
go back to reference Vandanmagsar B, Youm YH, Ravussin A et al (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17:179–188PubMedCentralPubMedCrossRef Vandanmagsar B, Youm YH, Ravussin A et al (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17:179–188PubMedCentralPubMedCrossRef
14.
go back to reference Schroder K, Zhou R, Tschopp J (2010) The NLRP3 inflammasome: a sensor for metabolic danger? Science 327:296–300PubMedCrossRef Schroder K, Zhou R, Tschopp J (2010) The NLRP3 inflammasome: a sensor for metabolic danger? Science 327:296–300PubMedCrossRef
15.
go back to reference Nishiyama A, Matsui M, Iwata S et al (1999) Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274:21645–21650PubMedCrossRef Nishiyama A, Matsui M, Iwata S et al (1999) Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274:21645–21650PubMedCrossRef
18.
go back to reference Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11:136–140PubMedCrossRef Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11:136–140PubMedCrossRef
19.
go back to reference Perrone L, Devi TS, Hosoya K, Terasaki T, Singh LP (2009) Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J Cell Physiol 221:262–272PubMedCrossRef Perrone L, Devi TS, Hosoya K, Terasaki T, Singh LP (2009) Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J Cell Physiol 221:262–272PubMedCrossRef
20.
go back to reference Al-Gayyar MM, Abdelsaid MA, Matragoon S, Pillai BA, El-Remessy AB (2011) Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity. Br J Pharmacol 164:170–180PubMedCrossRef Al-Gayyar MM, Abdelsaid MA, Matragoon S, Pillai BA, El-Remessy AB (2011) Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity. Br J Pharmacol 164:170–180PubMedCrossRef
21.
go back to reference Devi TS, Lee I, Huttemann M, Kumar A, Nantwi KD, Singh LP (2012) TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Müller glia under chronic hyperglycemia: implications for diabetic retinopathy. Exp Diabetes Res 2012:438238PubMedCentralPubMedCrossRef Devi TS, Lee I, Huttemann M, Kumar A, Nantwi KD, Singh LP (2012) TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Müller glia under chronic hyperglycemia: implications for diabetic retinopathy. Exp Diabetes Res 2012:438238PubMedCentralPubMedCrossRef
22.
go back to reference Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, Lee RT (2004) Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 279:30369–30374PubMedCrossRef Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, Lee RT (2004) Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 279:30369–30374PubMedCrossRef
23.
go back to reference Kowluru RA, Odenbach S (2004) Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants. Invest Ophthalmol Vis Sci 45:4161–4166PubMedCrossRef Kowluru RA, Odenbach S (2004) Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants. Invest Ophthalmol Vis Sci 45:4161–4166PubMedCrossRef
24.
go back to reference Knight SF, Quigley JE, Yuan J, Roy SS, Elmarakby A, Imig JD (2008) Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet. Hypertension 51:352–359PubMedCentralPubMedCrossRef Knight SF, Quigley JE, Yuan J, Roy SS, Elmarakby A, Imig JD (2008) Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet. Hypertension 51:352–359PubMedCentralPubMedCrossRef
25.
go back to reference Li W, Prakash R, Chawla D et al (2013) Early effects of high-fat diet on neurovascular function and focal ischemic brain injury. Am J Physiol Regul Integr Comp Physiol 304:R1001–R1008PubMedCrossRef Li W, Prakash R, Chawla D et al (2013) Early effects of high-fat diet on neurovascular function and focal ischemic brain injury. Am J Physiol Regul Integr Comp Physiol 304:R1001–R1008PubMedCrossRef
26.
go back to reference Al-Gayyar MM, Abdelsaid MA, Matragoon S, Pillai BA, El-Remessy AB (2010) Neurovascular protective effect of FeTPPs in N-methyl-d-aspartate model: similarities to diabetes. Am J Pathol 177:1187–1197PubMedCrossRef Al-Gayyar MM, Abdelsaid MA, Matragoon S, Pillai BA, El-Remessy AB (2010) Neurovascular protective effect of FeTPPs in N-methyl-d-aspartate model: similarities to diabetes. Am J Pathol 177:1187–1197PubMedCrossRef
27.
go back to reference Abdelsaid MA, Matragoon S, El-Remessy AB (2013) Thioredoxin interacting protein (TXNIP) expression is required for VEGF-mediated angiogenic signal in endothelial cells. Antioxid Redox Signal. doi:10.1089/ars.2012.4761 PubMed Abdelsaid MA, Matragoon S, El-Remessy AB (2013) Thioredoxin interacting protein (TXNIP) expression is required for VEGF-mediated angiogenic signal in endothelial cells. Antioxid Redox Signal. doi:10.​1089/​ars.​2012.​4761 PubMed
28.
go back to reference Faustin B, Reed JC (2013) Reconstituting the NLRP1 inflammasome in vitro. Methods Mol Biol 1040:137–152PubMedCrossRef Faustin B, Reed JC (2013) Reconstituting the NLRP1 inflammasome in vitro. Methods Mol Biol 1040:137–152PubMedCrossRef
29.
go back to reference Luo X, Yang Y, Shen T et al (2012) Docosahexaenoic acid ameliorates palmitate-induced lipid accumulation and inflammation through repressing NLRC4 inflammasome activation in HepG2 cells. Nutr Metab (Lond) 9:34CrossRef Luo X, Yang Y, Shen T et al (2012) Docosahexaenoic acid ameliorates palmitate-induced lipid accumulation and inflammation through repressing NLRC4 inflammasome activation in HepG2 cells. Nutr Metab (Lond) 9:34CrossRef
30.
go back to reference Knopp RH, Retzlaff B, Walden C, Fish B, Buck B, McCann B (2000) One-year effects of increasingly fat-restricted, carbohydrate-enriched diets on lipoprotein levels in free-living subjects. Proc Soc Exp Biol Med 225:191–199PubMedCrossRef Knopp RH, Retzlaff B, Walden C, Fish B, Buck B, McCann B (2000) One-year effects of increasingly fat-restricted, carbohydrate-enriched diets on lipoprotein levels in free-living subjects. Proc Soc Exp Biol Med 225:191–199PubMedCrossRef
31.
go back to reference Krogmann A, Staiger K, Haas C et al (2011) Inflammatory response of human coronary artery endothelial cells to saturated long-chain fatty acids. Microvasc Res 81:52–59PubMedCrossRef Krogmann A, Staiger K, Haas C et al (2011) Inflammatory response of human coronary artery endothelial cells to saturated long-chain fatty acids. Microvasc Res 81:52–59PubMedCrossRef
33.
go back to reference Wong TY, Duncan BB, Golden SH et al (2004) Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk in Communities study. Invest Ophthalmol Vis Sci 45:2949–2954PubMedCrossRef Wong TY, Duncan BB, Golden SH et al (2004) Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk in Communities study. Invest Ophthalmol Vis Sci 45:2949–2954PubMedCrossRef
34.
go back to reference Kawasaki R, Tielsch JM, Wang JJ et al (2008) The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata study. Br J Ophthalmol 92:161–166PubMedCrossRef Kawasaki R, Tielsch JM, Wang JJ et al (2008) The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata study. Br J Ophthalmol 92:161–166PubMedCrossRef
35.
go back to reference Huang SS, Khosrof SA, Koletsky RJ, Benetz BA, Ernsberger P (1995) Characterization of retinal vascular abnormalities in lean and obese spontaneously hypertensive rats. Clin Exp Pharmacol Physiol Suppl 22:S129–S131PubMedCrossRef Huang SS, Khosrof SA, Koletsky RJ, Benetz BA, Ernsberger P (1995) Characterization of retinal vascular abnormalities in lean and obese spontaneously hypertensive rats. Clin Exp Pharmacol Physiol Suppl 22:S129–S131PubMedCrossRef
36.
go back to reference Ferroni P, Basili S, Paoletti V, Davi G (2006) Endothelial dysfunction and oxidative stress in arterial hypertension. Nutr Metab Cardiovasc Dis 16:222–233PubMedCrossRef Ferroni P, Basili S, Paoletti V, Davi G (2006) Endothelial dysfunction and oxidative stress in arterial hypertension. Nutr Metab Cardiovasc Dis 16:222–233PubMedCrossRef
37.
go back to reference Coban E, Nizam I, Topal C, Akar Y (2010) The association of low-grade systemic inflammation with hypertensive retinopathy. Clin Exp Hypertens 32:528–531PubMedCrossRef Coban E, Nizam I, Topal C, Akar Y (2010) The association of low-grade systemic inflammation with hypertensive retinopathy. Clin Exp Hypertens 32:528–531PubMedCrossRef
38.
go back to reference Ellis EA, Grant MB, Murray FT et al (1998) Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 24:111–120PubMedCrossRef Ellis EA, Grant MB, Murray FT et al (1998) Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 24:111–120PubMedCrossRef
39.
go back to reference Galili O, Versari D, Sattler KJ et al (2007) Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am J Physiol Heart Circ Physiol 292:H904–H911PubMedCrossRef Galili O, Versari D, Sattler KJ et al (2007) Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am J Physiol Heart Circ Physiol 292:H904–H911PubMedCrossRef
40.
go back to reference Jebelovszki E, Kiraly C, Erdei N et al (2008) High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation. Am J Physiol Heart Circ Physiol 294:H2558–H2564PubMedCrossRef Jebelovszki E, Kiraly C, Erdei N et al (2008) High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation. Am J Physiol Heart Circ Physiol 294:H2558–H2564PubMedCrossRef
41.
go back to reference Gustavsson C, Agardh CD, Zetterqvist AV, Nilsson J, Agardh E, Gomez MF (2010) Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia. PLoS One 5:e12699PubMedCentralPubMedCrossRef Gustavsson C, Agardh CD, Zetterqvist AV, Nilsson J, Agardh E, Gomez MF (2010) Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia. PLoS One 5:e12699PubMedCentralPubMedCrossRef
42.
go back to reference Helfenstein T, Fonseca FA, Ihara SS et al (2011) Impaired glucose tolerance plus hyperlipidaemia induced by diet promotes retina microaneurysms in New Zealand rabbits. Int J Exp Pathol 92:40–49PubMedCentralPubMedCrossRef Helfenstein T, Fonseca FA, Ihara SS et al (2011) Impaired glucose tolerance plus hyperlipidaemia induced by diet promotes retina microaneurysms in New Zealand rabbits. Int J Exp Pathol 92:40–49PubMedCentralPubMedCrossRef
43.
go back to reference Symons JD, Abel ED (2013) Lipotoxicity contributes to endothelial dysfunction: a focus on the contribution from ceramide. Rev Endocr Metab Disord 14:59–68PubMedCrossRef Symons JD, Abel ED (2013) Lipotoxicity contributes to endothelial dysfunction: a focus on the contribution from ceramide. Rev Endocr Metab Disord 14:59–68PubMedCrossRef
44.
go back to reference Koenen TB, Stienstra R, van Tits LJ et al (2011) Hyperglycemia activates casp-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue. Diabetes 60:517–524PubMedCrossRef Koenen TB, Stienstra R, van Tits LJ et al (2011) Hyperglycemia activates casp-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue. Diabetes 60:517–524PubMedCrossRef
45.
go back to reference Lerner AG, Upton JP, Praveen PV et al (2012) IRE1alpha induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab 16:250–264PubMedCrossRef Lerner AG, Upton JP, Praveen PV et al (2012) IRE1alpha induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab 16:250–264PubMedCrossRef
46.
go back to reference Vincent JA, Mohr S (2007) Inhibition of casp-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes 56:224–230PubMedCrossRef Vincent JA, Mohr S (2007) Inhibition of casp-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes 56:224–230PubMedCrossRef
47.
go back to reference Galliher-Beckley AJ, Lan LQ, Aono S, Wang L, Shi J (2013) Casp-1 activation and mature interleukin-1beta release are uncoupled events in monocytes. World J Biol Chem 4:30–34PubMedCentralPubMedCrossRef Galliher-Beckley AJ, Lan LQ, Aono S, Wang L, Shi J (2013) Casp-1 activation and mature interleukin-1beta release are uncoupled events in monocytes. World J Biol Chem 4:30–34PubMedCentralPubMedCrossRef
48.
49.
go back to reference Park SY, Shi X, Pang J, Yan C, Berk BC (2013) Thioredoxin-interacting protein mediates sustained VEGFR2 signaling in endothelial cells required for angiogenesis. Arterioscler Thromb Vasc Biol 33:737–743PubMedCrossRef Park SY, Shi X, Pang J, Yan C, Berk BC (2013) Thioredoxin-interacting protein mediates sustained VEGFR2 signaling in endothelial cells required for angiogenesis. Arterioscler Thromb Vasc Biol 33:737–743PubMedCrossRef
50.
go back to reference Wu N, Zheng B, Shaywitz A et al (2013) AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. Mol Cell 49:1167–1175PubMedCrossRef Wu N, Zheng B, Shaywitz A et al (2013) AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. Mol Cell 49:1167–1175PubMedCrossRef
Metadata
Title
Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet
Authors
Islam N. Mohamed
Sherif S. Hafez
Arwa Fairaq
Adviye Ergul
John D. Imig
Azza B. El-Remessy
Publication date
01-02-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 2/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-3101-z

Other articles of this Issue 2/2014

Diabetologia 2/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.